Global Diabetes Management Devices Market 2024-2028

The diabetes management devices market is forecasted to grow by USD 13.98 bn during 2023-2028, accelerating at a CAGR of 7.68% during the forecast period. The report on the diabetes management devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising global burden of diabetes, growing demand for advanced insulin delivery devices, and new product launches.

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	7.22%
CAGR	7.68%
Incremental Value	$13.98bn

Technavio's diabetes management devices market is segmented as below:

By Product

Blood glucose monitoring devices
Insulin delivery systems

By Distribution Channel

Offline
Online

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing focus on artificial pancreas as one of the prime reasons driving the diabetes management devices market growth during the next few years. Also, increasing focus on home care settings and technological advancements in healthcare sector will lead to sizable demand in the market.

The report on the diabetes management devices market covers the following areas:

Diabetes management devices market sizing
Diabetes management devices market forecast
Diabetes management devices market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading diabetes management devices market vendors that include Abbott Laboratories, ACON Laboratories Inc., B.Braun SE, Becton Dickinson and Co., Bionime Corp., Dexcom Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., iHealth Labs Inc., Insulet Corp., LifeScan IP Holdings LLC, Medtronic Plc, Nemaura Medical Inc., Nipro Corp., Nova Biomedical Corp., Novo Nordisk AS, PHC Holdings Corp., Prodigy Diabetes Care LL, Tandem Diabetes Care Inc., and WellDoc Inc.. Also, the diabetes management devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR70599

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global diabetes management devices market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global diabetes management devices market 2018 - 2022 ($ billion)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.3 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Blood glucose monitoring devices - Market size and forecast 2023-2028
Exhibit 34: Chart on Blood glucose monitoring devices - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Blood glucose monitoring devices - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Blood glucose monitoring devices - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Blood glucose monitoring devices - Year-over-year growth 2023-2028 (%)
6.4 Insulin delivery systems - Market size and forecast 2023-2028
Exhibit 38: Chart on Insulin delivery systems - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Insulin delivery systems - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Insulin delivery systems - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Insulin delivery systems - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ billion)
Exhibit 43: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by Distribution Channel

7.1 Market segments
Exhibit 44: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 45: Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Exhibit 46: Chart on Comparison by Distribution Channel
Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2023-2028
Exhibit 48: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibit 49: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibit 50: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Offline - Year-over-year growth 2023-2028 (%)
7.4 Online - Market size and forecast 2023-2028
Exhibit 52: Chart on Online - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Online - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Distribution Channel
Exhibit 56: Market opportunity by Distribution Channel ($ billion)
Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 83: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 France - Market size and forecast 2023-2028
Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
9.11 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 107: Abbott Laboratories - Overview
Exhibit 108: Abbott Laboratories - Business segments
Exhibit 109: Abbott Laboratories - Key news
Exhibit 110: Abbott Laboratories - Key offerings
Exhibit 111: Abbott Laboratories - Segment focus
12.4 B.Braun SE
Exhibit 112: B.Braun SE - Overview
Exhibit 113: B.Braun SE - Business segments
Exhibit 114: B.Braun SE - Key news
Exhibit 115: B.Braun SE - Key offerings
Exhibit 116: B.Braun SE - Segment focus
12.5 Becton Dickinson and Co.
Exhibit 117: Becton Dickinson and Co. - Overview
Exhibit 118: Becton Dickinson and Co. - Business segments
Exhibit 119: Becton Dickinson and Co. - Key news
Exhibit 120: Becton Dickinson and Co. - Key offerings
Exhibit 121: Becton Dickinson and Co. - Segment focus
12.6 Bionime Corp.
Exhibit 122: Bionime Corp. - Overview
Exhibit 123: Bionime Corp. - Product / Service
Exhibit 124: Bionime Corp. - Key offerings
12.7 Eli Lilly and Co.
Exhibit 125: Eli Lilly and Co. - Overview
Exhibit 126: Eli Lilly and Co. - Product / Service
Exhibit 127: Eli Lilly and Co. - Key news
Exhibit 128: Eli Lilly and Co. - Key offerings
12.8 F. Hoffmann La Roche Ltd.
Exhibit 129: F. Hoffmann La Roche Ltd. - Overview
Exhibit 130: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 131: F. Hoffmann La Roche Ltd. - Key news
Exhibit 132: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 133: F. Hoffmann La Roche Ltd. - Segment focus
12.9 iHealth Labs Inc.
Exhibit 134: iHealth Labs Inc. - Overview
Exhibit 135: iHealth Labs Inc. - Product / Service
Exhibit 136: iHealth Labs Inc. - Key offerings
12.10 Insulet Corp.
Exhibit 137: Insulet Corp. - Overview
Exhibit 138: Insulet Corp. - Product / Service
Exhibit 139: Insulet Corp. - Key news
Exhibit 140: Insulet Corp. - Key offerings
12.11 LifeScan IP Holdings LLC
Exhibit 141: LifeScan IP Holdings LLC - Overview
Exhibit 142: LifeScan IP Holdings LLC - Product / Service
Exhibit 143: LifeScan IP Holdings LLC - Key offerings
12.12 Medtronic Plc
Exhibit 144: Medtronic Plc - Overview
Exhibit 145: Medtronic Plc - Business segments
Exhibit 146: Medtronic Plc - Key news
Exhibit 147: Medtronic Plc - Key offerings
Exhibit 148: Medtronic Plc - Segment focus
12.13 Nemaura Medical Inc.
Exhibit 149: Nemaura Medical Inc. - Overview
Exhibit 150: Nemaura Medical Inc. - Product / Service
Exhibit 151: Nemaura Medical Inc. - Key offerings
12.14 Nipro Corp.
Exhibit 152: Nipro Corp. - Overview
Exhibit 153: Nipro Corp. - Business segments
Exhibit 154: Nipro Corp. - Key offerings
Exhibit 155: Nipro Corp. - Segment focus
12.15 Nova Biomedical Corp.
Exhibit 156: Nova Biomedical Corp. - Overview
Exhibit 157: Nova Biomedical Corp. - Product / Service
Exhibit 158: Nova Biomedical Corp. - Key offerings
12.16 Novo Nordisk AS
Exhibit 159: Novo Nordisk AS - Overview
Exhibit 160: Novo Nordisk AS - Business segments
Exhibit 161: Novo Nordisk AS - Key offerings
Exhibit 162: Novo Nordisk AS - Segment focus
12.17 PHC Holdings Corp.
Exhibit 163: PHC Holdings Corp. - Overview
Exhibit 164: PHC Holdings Corp. - Business segments
Exhibit 165: PHC Holdings Corp. - Key offerings
Exhibit 166: PHC Holdings Corp. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 167: Inclusions checklist
Exhibit 168: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 169: Currency conversion rates for US$
13.4 Research methodology
Exhibit 170: Research methodology
Exhibit 171: Validation techniques employed for market sizing
Exhibit 172: Information sources
13.5 List of abbreviations
Exhibit 173: List of abbreviations